,,ii  #aag? ,,congress  #a/ ,session    
,s4 #aagf  ,,9 ,,! ,,s5ate ,,( ,,!      
,,unit$ ,,/ates  ,april #ae1 #bjba,ms4  
,smi? 7= h]self & ,mr4 ,cassidy7        
introduc$ ! foll[+ bill2 :i* 0 read     
twice & ref]r$ to ! ,committee on       
,heal?1 ,education1 ,labor1 & ,p5sions  
,a ,,bill  ,to e/abli% a grant program  
to support ! manufacture & /ockpil+ (   
ess5tial g5]ic antibiotic drugs4  #a4   
,%ort title ,?is ,act may be cit$ z !   
,on%or+ ,ess5tial ,antibiotics ,act4    
#b4 ,ess5tial g5]ic antibiotic program  
7a7 ,grant program  7#a7 ,e/abli%m5t ,n 
lat] ?an #fj days aft] ! date ( enactm5t
 ( ?is ,act1 ! ,secret>y %all e/abli% a 
program to provide grants to            
manufactur]s ( ess5tial g5]ic antibiotic
 drugs1 or ! active ph>maceutical +r$i5t
 or key />t+ mat]ial ( an ess5tial g5]ic
 antibiotic drug1 to support activities 
describ$ 9 p>agraph 7#c74  7#b7         
,eligible entities ,! ,secret>y %all    
aw>d grants "u ?is subsection to n m ?an
 #c manufactur]s ( an ess5tial g5]ic    

antibiotic drug4 ,ea* su* recipi5t %all 
be a manufactur] t-- 7,a7 has implem5t$ 
& ma9ta9s an effective quality managem5t
 sy/em1 "u p>ts #baj & #baa ( title #ba1
 ,code ( ,f$]al ,regulations 7or any    
successor regulations72  7,b7 has a     
/rong record ( compliance ) !           
requirem5ts ( ! ,f$]al ,food1 ,drug1 &  
,cosmetic ,act 7#ba ,u4,s4,c4 #cja et   
seq472  7,c7 uses complex ph>maceutical 
manufactur+ to produce a f9i%$ drug     
product or active ph>maceutical +r$i5t  
pursuant to an application approv$ "u   
section subsection 7c7 or 7j7 ( section 
#eje ( ! ,f$]al ,food1 ,drug1 &         
,cosmetic ,act 7#ba ,u4,s4,c4 #cee72    
7,d7 commits to us+ advanc$ manufactur+ 
9 its manufactur+ op]ations2 &  7,e7 has
 exi/+ manufactur+ facilities &         
op]ations 9 ! ,unit$ ,/ates4  7#c7 ,use 
( funds ,a recipi5t ( a grant "u ?is    
subsection may use su* grant funds to-- 
7,a7 ) respect to manufactur+ an        
ess5tial g5]ic antibiotic drug-- 7i7    
exp&1 upgrade1 or recommission an exi/+ 

manufactur+ facility locat$ 9 ! ,unit$  
,/ates2 or  7ii7 con/ruct a new         
manufactur+ facility 9 ! ,unit$ ,/ates2 
&  7,b7 manufacture ess5tial g5]ic      
antibiotic drugs4  7b7 ,use ( funds ,to 
pur*ase ess5tial g5]ic antibiotic drugs 
= /ockpil+ ,! ,secret>y may use am\nts  
appropriat$ "u ?is section to pur*ase1  
/ore1 /ockpile1 or disposition ess5tial 
g5]ic antibiotic drugs manufactur$ 9 !  
,unit$ ,/ates4  7c7 ,def9itions ,=      
purposes ( ?is section3 7#a7 ,active    
ph>maceutical +r$i5t ,! t]m active      
ph>maceutical +r$i5t has ! mean+ giv5   
su* t]m 9 section #gdd;,a ( ! ,f$]al    
,food1 ,drug1 & ,cosmetic ,act 7#ba     
,u4,s4,c4 #cgi;j-#da74  7#b7 ,ess5tial  
g5]ic antibiotic drug ,! t]m ess5tial   
g5]ic antibiotic drug means an          
antibact]ial or antifungal drug approv$ 
by ! ,food & ,drug ,adm9i/ration "u     
section #eje7;j7 ( ! ,f$]al ,food1      
,drug1 & ,cosmetic ,act 7#ba ,u4,s4,c4  
#cee7;j77 t ! ,secret>y det]m9es to be  
m$ically necess>y to h available at all 

times 9 an am\nt adequate to s]ve pati5t
 ne$s1 includ+ beta-lactams 7includ+    
p5icill9 & cephalospor9 d]ivatives7 &   
non-beta lactams 7includ+ tetracycl9e & 
am9oglycoside d]ivatives74  7#c7 ,key   
/>t+ mat]ial ,! t]m key />t+ mat]ial    
means any compon5t ( a drug t !         
,secret>y det]m9es to be critical to !  
safety & effectiv5ess ( ! drug4  7#d7   
,secret>y ,! t]m ,secret>y means !      
,secret>y ( ,heal? & ,human ,s]vices4   
7#e7 ,unit$ ,/ates ,! t]m ,unit$ ,/ates 
means ! #ej ,/ates1 ! ,di/rict (        
,columbia1 t]ritories1 & ,tribal l&s4   
7d7 ,fund+ ,= purposes ( c>ry+ out ?is  
section1 !re is appropriat$1 out (      
am\nts 9 ! ,treasury n o!rwise          
appropriat$1 #ejj1jjj1jjj = fiscal ye>  
#bjba1 to rema9 available ?r\gh         
,septemb] #cj1 #bjbc4  #c4 ,/udy &      
report  7a7 ,9 g5]al ,! ,secret>y (     
,heal? & ,human ,s]vices 7ref]r$ to 9   
?is section z ! ,secret>y7 %all ent]    
into a contract ) an entity "u :i* su*  
entity c>ries out a /udy on !           

manufacture ( ess5tial g5]ic antibiotic 
drugs & issues a report t includes--    
7#a7 recomm5dations ab\t :i* antibiotics
 ! ,secret>y %\ld prioritize = purposes 
( ! program "u section #b1 bas$ on      
factors t include necessity ( use1      
vuln]ability to =eign supply *a9        
disruptions1 & availability (           
alt]natives2 &  7#b7 ! expect$ effect ( 
increas$ dome/ic manufactur+ ( drugs on 
drug co/s to consum]s4  7b7             
,au?orization ,to c>ry out ?is section1 
!re is au?oriz$ to be appropriat$       
#b1jjj1jjj = fiscal ye> #bjba1 to rema9 
available until ,septemb] #cj1 #bjbb4